Acadia Pharmaceuticals (ACAD) PT Raised to $23 at Oppenheimer
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $20.26 -1.32%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 35
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 35
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $23.00 (from $20.00) while maintaining a Perform rating.
You May Also Be Interested In
- Acadia Pharmaceuticals (ACAD) PT Lowered to $33 at H.C. Wainwright
- Acadia Pharmaceuticals (ACAD) PT Lowered to $35 at Needham
- Ferrari NV (RACE:IM) (RACE) PT Raised to EUR421 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
